Effects of TCDD on the EGF receptor of XB mouse keratinizing epithelial cells
- 1 September 1989
- journal article
- research article
- Published by Wiley in Journal of Biochemical Toxicology
- Vol. 4 (3) , 173-182
- https://doi.org/10.1002/jbt.2570040306
Abstract
TCDD was found to cause a marked inhibition of 125I-epidermal growth factor (EGF) binding to its receptor on the cell surface of XB mouse keratinizing epithelial cells (XB cells) cultured in vitro. The EC50 concentration was estimated to be on the order of 3 × 10−11 M 24 hours after TCDD administration. As early as 12 hours after the addition of 10−9 M of TCDD, XB cells showed signs of a decline in 125I-EGF binding levels. The level of such EGF receptor downregulation reached a maximum at 24 hours, continued until day 2, but completely recovered by day 3. This was accompanied by a rise in protein kinase activities, particularly those of the protein tyrosine kinases during the initial period of 6–24 hours. To test the hypothesis that the EGF receptors of the cells, by showing TCDD-induced symptoms of downregulation, actually are being activated and triggering EGF-like signals, we examined the effects of both TCDD and exogenously added EGF on cell morphology, colony formation degree of keratinization, the pattern of activation of protein kinases and de novo protein synthesis, and EGF receptor phosphorylation. Based on the similarity of cell responses to these between TCDD- and EGF-treated cells, we concluded that TCDD, directly or indirectly, causes activation of the EGF receptor. In contrast, 12-O-tetradencanoylphorbol-13-acetate (TPA), which is known to downregulate EGF receptors by blocking their protein tyrosine kinase, produced dissimilar end results. The balance of evidence support the notion that the action of TCDD in this cell line is tightly coupled to the activation of the EGF receptor and that one of the key consequences of such a biochemical change is that it signals these cells to commit to terminal differentiation.Keywords
This publication has 34 references indexed in Scilit:
- TCDD (2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin) causes an increase in protein tyrosine kinase activities at an early stage of poisoning in rat hepatocyte membranesLife Sciences, 1987
- 2,3,7,8‐tetrachlorodibenzo‐p‐ dioxin reduces high‐affinity binding of epidermal growth factor to cell surface receptors in C3H 10T1/2 cellsJournal of Biochemical Toxicology, 1986
- 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) enhances terminal differentiation of cultured human epidermal cellsToxicology and Applied Pharmacology, 1985
- TCDD (2,3,7,8-tetrachlorodibenzo-p-dioxin) causes increases in protein kinases particularly protein kinase C in the hepatic plasma membrane of the rat and the guinea pigBiochemical and Biophysical Research Communications, 1985
- Alteration of rat hepatic plasma membrane functions by 2,3,7,8-tetrachlorodibenzo-p-dioxin(TCDD)Archives of Environmental Contamination and Toxicology, 1984
- 2,3,7,8-Tetrachlorodibenzo-p-dioxin Induces Hyperplasia in Confluent Cultures of Human KeratinocytesJournal of Investigative Dermatology, 1984
- Biochemical aspects of action mechanisms of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and related chemicals in animalsPharmacology & Therapeutics, 1982
- Keratinization of mouse teratoma cell line XB produced by 2,3,7,8-tetrachlorodibenzo-p-dioxin: An in vitro model of toxicityCell, 1980
- 2,3,7,8-Tetrachlorodibenzo-p-dioxin: Failure to demonstrate toxicity in twenty-three cultured cell typesToxicology and Applied Pharmacology, 1980
- The Stimulation of Epidermal Keratinization by a Protein Isolated from the Submaxillary Gland of the Mouse**From the Department of Biochemistry and the Department of Pathology, Vanderbilt University School of Medicine, Nashville, Tennessee.Journal of Investigative Dermatology, 1963